ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

Clinical Research Programs Could Be Accredited, IOM Says.

April 20, 2001

National Policy: IOM Seeks Nominations for Cancer Policy Board

November 29, 1996

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

July 13, 2007

In Brief: Centers Awarded Gifts; Georgetown Launches $40m Campaign; Herberman Named To PA Board

February 1, 1991

In Brief: AMOS Says Cancer Program Should Not Have Ceiling Of $1 Billion; OSHA Drops Effort To Fire Infants

August 14, 1981

New Jersey Commission Calls For Major Hike In Cancer Spending

September 25, 1987